Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.44 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.44 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30287355 | 1.00 | AOC3 (0.54) | AOC3KDM4EALDH1A1GAAMAPK1 | |
| SCHEMBL27075383 | 0.82 | AOC3 (0.52) | AOC3KDM4EALDH1A1GAAMAPK1 | |
| SCHEMBL28488611 | 0.80 | AOC3 (0.50) | AOC3KDM4EALDH1A1GAAMAPK1 | |
| SCHEMBL10826335 | 0.78 | FLT3 (0.48) | AOC3KDM4EALDH1A1GAAMAPK1 | |
| SCHEMBL29636187 | 0.78 | AOC3 (0.48) | AOC3KDM4EALDH1A1GAAMAPK1 | |
| SCHEMBL3191163 | 0.78 | AOC3 (0.48) | AOC3KDM4EALDH1A1GAAMAPK1 | |
| SCHEMBL31232953 | 0.78 | FLT3 (0.48) | AOC3KDM4EALDH1A1GAAMAPK1 | |
| Iodide SCHEMBL28673444 | 0.77 | AOC3 (0.47) | AOC3KDM4EALDH1A1GAAMAPK1 | |
| Phosphine SCHEMBL28563766 | 0.77 | AOC3 (0.47) | AOC3KDM4EALDH1A1GAAMAPK1 | |
| SCHEMBL29563733 | 0.75 | MAPT (0.59) | AOC3KDM4EALDH1A1GAANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109071634-A | Antibody coupling matter and its preparation and application | R.P.谢勒技术有限责任公司 | 2018-12-21 | — | — | CN | claimed |
| WO-2018169953-A1 | ANTIBODY CONJUGATES AND METHODS OF MAKING AND USING THE SAME | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2018-09-20 | — | — | WO | claimed |
| WO-2017189432-A1 | ANTIBODY CONJUGATES AND METHODS OF MAKING AND USING THE SAME | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2017-11-02 | — | — | WO | claimed |
| US-20170306300-A1 | ANTIBODY CONJUGATES AND METHODS OF MAKING AND USING THE SAME | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2017-10-26 | — | — | US | claimed |
| US-20250381290-A1 | Antibody Conjugates and Methods of Making and Using the Same | SCHERER TECHNOLOGIES LLC R P (US) | 2025-12-18 | — | — | US | disclosed |
| EP-4592275-A2 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | Redwood Bioscience, Inc. (US) | 2025-07-30 | — | — | EP | disclosed |
| EP-3074010-B1 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | REDWOOD BIOSCIENCE INC (US) | 2025-05-14 | — | — | EP | disclosed |
| US-12296021-B2 | Antibody conjugates and methods of making and using the same | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2025-05-13 | — | — | US | disclosed |
| WO-2025064427-A1 | DUAL-PAYLOAD ANTIBODY-DRUG CONJUGATES AND USES THEREOF | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2025-03-27 | — | — | WO | disclosed |
| US-12215080-B2 | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate | REDWOOD BIOSCIENCE, INC. (US) | 2025-02-04 | — | — | US | disclosed |
| US-12076411-B2 | Anti-HER2 antibody-maytansine conjugates and methods of use thereof | REDWOOD BIOSCIENCE, INC. (US) | 2024-09-03 | — | — | US | disclosed |
| US-20240101975-A1 | Antibody Conjugates and Methods of Making and Using the Same | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2024-03-28 | — | — | US | disclosed |
| WO-2014078566-A1 | HYDRAZINYL-INDOLE COMPOUNDS AND CONJUGATES | REDWOOD BIOSCIENCE, INC. (US) | 2014-05-22 | — | — | WO | disclosed |
| WO-2014078566-A1 | HYDRAZINYL-INDOLE COMPOUNDS AND CONJUGATES | REDWOOD BIOSCIENCE, INC. (US) | 2014-05-22 | — | — | WO | disclosed |
| US-20140141025-A1 | HYDRAZINYL-INDOLE COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | REDWOOD BIOSCIENCE, INC. (US) | 2014-05-22 | — | — | US | disclosed |
| US-20100179122-A1 | Non-Nucleoside Reverse Transcriptase Inhibitors | MERCK SHARP & DOHME CORP. | 2010-07-15 | — | — | US | disclosed |
| EP-1898927-A2 | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | Merck & Co., Inc. (US) | 2008-03-19 | — | — | EP | disclosed |
| WO-2007002481-A2 | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | MERCK & CO., INC. (US) | 2007-01-04 | — | — | WO | disclosed |
| US-4600721-A | ENZYME INHIBITORS, ANTIINFLAMMATORY, ANTIPYRETICS, BENZOTHIAZOLE AND BENZOXAZOLE HYDRAZINES | LUDWIG HEUMANN & CO., GMBH (DE) | 1986-07-15 | — | — | US | disclosed |
| US-4476137-A | ANTIINFLAMMATORY AGENTS | ABBOTT LABORATORIES (US) | 1984-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100179122-A1 | Non-Nucleoside Reverse Transcriptase Inhibitors | RNGTT, RTF1, POLR1E | AOC3 3700/4885KDM4E 1660/4885ALDH1A1 1178/4885 |
| US-20140141025-A1 | HYDRAZINYL-INDOLE COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | HNMT, AANAT, INMT | AOC3 2022/4885KDM4E 3088/4885ALDH1A1 1454/4885 |
| US-20250381290-A1 | Antibody Conjugates and Methods of Making and Using the Same | PFAS, FGR, FGB | AOC3 1544/4885KDM4E 903/4885ALDH1A1 1880/4885 |
| US-12215080-B2 | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate | DNPEP, QPCT, PDS5A | AOC3 2218/4885KDM4E 2215/4885ALDH1A1 1538/4885 |
| US-12076411-B2 | Anti-HER2 antibody-maytansine conjugates and methods of use thereof | ERBB2, EGFR, ERBB3 | AOC3 3034/4885KDM4E 2372/4885ALDH1A1 1950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.